LT3288578T - Kompozicijos, skirtos gaubtinės žarnos valymui ir virškinimo trakto sutrikimų gydymui - Google Patents

Kompozicijos, skirtos gaubtinės žarnos valymui ir virškinimo trakto sutrikimų gydymui

Info

Publication number
LT3288578T
LT3288578T LTEPPCT/US2016/030061T LT16030061T LT3288578T LT 3288578 T LT3288578 T LT 3288578T LT 16030061 T LT16030061 T LT 16030061T LT 3288578 T LT3288578 T LT 3288578T
Authority
LT
Lithuania
Prior art keywords
compositions
treatment
gastrointestinal disorders
colon cleansing
cleansing
Prior art date
Application number
LTEPPCT/US2016/030061T
Other languages
English (en)
Lithuanian (lt)
Inventor
Mark Currie
Robert SOLINGA
Christopher Leitheiser
Original Assignee
Ironwood Pharmaceuticals, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ironwood Pharmaceuticals, Inc. filed Critical Ironwood Pharmaceuticals, Inc.
Publication of LT3288578T publication Critical patent/LT3288578T/lt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Urology & Nephrology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
LTEPPCT/US2016/030061T 2015-05-01 2016-04-29 Kompozicijos, skirtos gaubtinės žarnos valymui ir virškinimo trakto sutrikimų gydymui LT3288578T (lt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562156077P 2015-05-01 2015-05-01
PCT/US2016/030061 WO2016178979A1 (en) 2015-05-01 2016-04-29 Compositions for colon cleansing and the treatment of gastrointestinal disorders

Publications (1)

Publication Number Publication Date
LT3288578T true LT3288578T (lt) 2023-04-25

Family

ID=55953439

Family Applications (1)

Application Number Title Priority Date Filing Date
LTEPPCT/US2016/030061T LT3288578T (lt) 2015-05-01 2016-04-29 Kompozicijos, skirtos gaubtinės žarnos valymui ir virškinimo trakto sutrikimų gydymui

Country Status (23)

Country Link
US (2) US10618938B2 (enExample)
EP (2) EP3288578B8 (enExample)
JP (5) JP6930919B2 (enExample)
KR (2) KR102783759B1 (enExample)
CN (2) CN108040482B (enExample)
CA (2) CA3172777A1 (enExample)
CY (1) CY1126031T1 (enExample)
DK (1) DK3288578T5 (enExample)
EA (1) EA201792401A1 (enExample)
ES (1) ES2947591T3 (enExample)
FI (1) FI3288578T3 (enExample)
HR (1) HRP20230381T1 (enExample)
HU (1) HUE061954T2 (enExample)
LT (1) LT3288578T (enExample)
MA (1) MA41985B1 (enExample)
MD (1) MD3288578T2 (enExample)
MX (2) MX2017013928A (enExample)
PL (1) PL3288578T3 (enExample)
PT (1) PT3288578T (enExample)
RS (1) RS64160B1 (enExample)
SI (1) SI3288578T1 (enExample)
SM (1) SMT202300114T1 (enExample)
WO (1) WO2016178979A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6930919B2 (ja) * 2015-05-01 2021-09-01 アイアンウッド ファーマシューティカルズ インコーポレイテッド 結腸洗浄及び胃腸障害の治療のための組成物
PL3464336T3 (pl) 2016-06-01 2022-05-16 Athira Pharma, Inc. Związki
JP2024541769A (ja) * 2021-11-24 2024-11-12 アイアンウッド ファーマシューティカルズ， インコーポレイテッド 修飾ｇｃｃ受容体アゴニストの産生のための合成プロセス
AU2022397387A1 (en) * 2021-11-24 2024-05-30 Ironwood Pharmaceuticals, Inc. Synthetic process for production of modified gcc receptor agonists
JP2024541570A (ja) 2021-11-29 2024-11-08 アイアンウッド ファーマシューティカルズ， インコーポレイテッド 内臓痛の処置のための医薬組成物

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH689139A5 (de) 1995-04-03 1998-10-30 Cerbios Pharma Sa Verfahren zur Herstellung einer liposomalen, in Wasser dispergierbaren, oral zu verabreichenden, festen, trockenen therapeutischen Formulierung.
US5912014A (en) 1996-03-15 1999-06-15 Unigene Laboratories, Inc. Oral salmon calcitonin pharmaceutical products
DE602004007105T2 (de) * 2003-01-28 2008-02-28 Microbia Inc., Cambridge Zusammensetzung zur behandlung von gastrointestinalen störungen
US7494979B2 (en) * 2003-06-13 2009-02-24 Ironwood Pharmaceuticals, Inc. Method for treating congestive heart failure and other disorders
EP1940441A4 (en) * 2005-08-19 2010-01-27 Ironwood Pharmaceuticals Inc COMPOSITIONS AND METHODS FOR TREATING GASTROINTESTINAL DISORDERS
WO2010025510A1 (en) * 2008-09-03 2010-03-11 Xenome Ltd Libraries of peptide conjugates and methods for making them
EA201290799A1 (ru) * 2010-02-17 2013-03-29 Айронвуд Фармасьютикалз, Инк. Лечение желудочно-кишечных расстройств
EP3366698A1 (en) * 2011-03-01 2018-08-29 Synergy Pharmaceuticals Inc. Guanylate cyclase c agonists
AU2014218599C1 (en) * 2013-02-25 2018-09-06 Bausch Health Ireland Limited Guanylate cyclase receptor agonists for use in colonic cleansing
EP3004138B1 (en) 2013-06-05 2024-03-13 Bausch Health Ireland Limited Ultra-pure agonists of guanylate cyclase c, method of making and using same
WO2016015055A1 (en) 2014-07-25 2016-01-28 Ironwood Pharmaceuticals, Inc. Colon cleansing compositions
JP6930919B2 (ja) * 2015-05-01 2021-09-01 アイアンウッド ファーマシューティカルズ インコーポレイテッド 結腸洗浄及び胃腸障害の治療のための組成物

Also Published As

Publication number Publication date
JP6930919B2 (ja) 2021-09-01
PT3288578T (pt) 2023-03-28
KR102783759B1 (ko) 2025-03-21
JP2025169325A (ja) 2025-11-12
EP4218789A3 (en) 2023-09-27
CY1126031T1 (el) 2023-11-15
EP3288578B1 (en) 2023-03-15
KR20250042844A (ko) 2025-03-27
EP3288578A1 (en) 2018-03-07
SI3288578T1 (sl) 2023-07-31
US10618938B2 (en) 2020-04-14
DK3288578T3 (da) 2023-05-01
JP2024015335A (ja) 2024-02-01
CN114716514A (zh) 2022-07-08
KR20180005675A (ko) 2018-01-16
JP2022121734A (ja) 2022-08-19
JP2020203954A (ja) 2020-12-24
HUE061954T2 (hu) 2023-09-28
US20180148476A1 (en) 2018-05-31
CN108040482A (zh) 2018-05-15
EP3288578B8 (en) 2023-03-29
CA2984437C (en) 2025-11-18
SMT202300114T1 (it) 2023-05-12
MX2022013283A (es) 2022-12-13
CN108040482B (zh) 2022-03-29
FI3288578T3 (fi) 2023-05-03
MA41985B1 (fr) 2023-04-28
RS64160B1 (sr) 2023-05-31
CA2984437A1 (en) 2016-11-10
BR112017023539A2 (pt) 2018-08-14
DK3288578T5 (da) 2024-10-07
HRP20230381T1 (hr) 2023-07-07
PL3288578T3 (pl) 2023-08-14
MD3288578T2 (ro) 2023-08-31
US20240199697A1 (en) 2024-06-20
EA201792401A1 (ru) 2018-05-31
ES2947591T3 (es) 2023-08-11
MA41985A (fr) 2018-03-07
MX2017013928A (es) 2018-01-15
JP2018519254A (ja) 2018-07-19
WO2016178979A1 (en) 2016-11-10
CA3172777A1 (en) 2016-11-10
EP4218789A2 (en) 2023-08-02

Similar Documents

Publication Publication Date Title
IL289650A (en) Azolopyrimidine for the treatment of cancer-related disorders
IL273693A (en) Treatment of inflammatory disorders
IL246833A0 (en) New salts and their pharmaceutical preparations for the treatment of inflammatory disorders
IL255109A0 (en) New dihydropyridoisoquinolinones and their pharmaceutical preparations for the treatment of inflammatory disorders
GB201402070D0 (en) Pharmaceutical compositions for the treatment of inflammatory disorders
IL262348A (en) Preparations for the treatment of excessive radiation disorders
GB201411241D0 (en) Novel dihydropyridoisoquinolinones and pharmaceutical compositions thereof for the treatment of inflammatory disorders
GB201608046D0 (en) Treatment of complement-mediated disorders
IL258032A (en) Compounds and preparations for the treatment of ocular disorders
GB201401086D0 (en) Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders
GB201610056D0 (en) Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders and osteoarthritis
PL3348273T3 (pl) Kompozycje na bazie ksyloglukanu i białek do leczenia zaburzeń jelitowych
HUE061954T2 (hu) Vastagbél tisztítására és gyomor-bélrendszeri rendellenességek kezelésére szolgáló készítmények
GB201610055D0 (en) Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders and osteoarthritis
GB201607388D0 (en) Treatment of impulsivity-related disorders
ZA201706985B (en) Compositions for the treatment of fibrosis and fibrosis-related conditions
ZA201903222B (en) Compositions and methods for the treatment of gastrointestinal polyps
SG11201706952VA (en) Compositions and methods for the treatment of epilepsy and neurological disorders
IL254140A0 (en) Preparations and combinations for use in the treatment of angiogenic diseases and disorders
GB201602784D0 (en) New treatment of CFTR-related disorders
SG11201606834QA (en) Method of cleansing the colon